
CRBP vs GSK
$CRBP vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CRBP vs GSK: the quick read
- ·GSK is the larger company by market cap ($95.11B vs $106M).
- ·CRBP has been more active on our scanner (132 vs 71 alerts in 30 days).
- ·CRBP has the smaller float (18.7M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·CRBP trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 132 and 71 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 896x the market cap of CRBP, so the same dollar of news moves CRBP far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and CRBP does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CRBP and GSK on TheDesperateTrader.
- Is CRBP or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.11B vs $106M). CRBP has been more active on our scanner (132 vs 71 alerts in 30 days). CRBP has the smaller float (18.7M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CRBP and GSK?
- The differences that matter: GSK is roughly 896x the size of the other by market cap ($106M vs $95.11B); they trade at very different share prices ($5.63 vs $46.74); CRBP sits at 1% of its 52-week range against 21% for GSK; only GSK pays a dividend; our scanner flagged CRBP 132 times in the last 30 days against 71 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of CRBP and GSK is more active right now?
- Right now CRBP is at about 1.1x its normal volume and GSK is at about 1.7x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CRBP or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore CRBP and GSK comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.